Ammonium excretion by the mammalian kidney is a rate-limited process that involves the de novo synthesis of NH8 by the renal tubular epithelial cells and the subsequent transfer of the ammonia from cell water to tubular fluid. Biologically, this process serves to increase markedly the capacity of the kidney to excrete hydrogen ions, for NH, is a strong base, and in an acidic urine virtually all of the NH. molecules will combine with hydrogen ions to form NHh. This in turn will contribute to the maintenance of a gradient favoring further secretion of protons.
In health, ammonium excretion accounts for a significant fraction of the total hydrogen ion excreted in the urine, and in acidosis the rate of NH4+ excretion increases strikingly. However, if acidosis is sustained, ammonium excretion will reach a plateau within a few days, and the excretion rate will not increase spontaneously thereafter (1) . On the other hand, if amino acid precursor substrates, such as alanine and glutamine, are infused after the excretion rate has reached its apparent maximum, a substantial increase in excretion will occur (2) .
In chronic renal disease, ammonium excretion rates are diminished despite the presence of chronic acidosis (3) . Uncertainty persists, however, about the genesis of this decrease. Obviously the upper limit of ammonium excretion achieved by any kidney cannot exceed the average maximal rate of excretion per nephron times the number of urine-forming nephrons, and it is implicit in the nature of the progressive renal diseases that the total nephron population diminishes with time. It is not clear, however, whether ammonia synthesis in the surviving nephrons is impaired, normal, or, as Elkinton (4) has suggested, supernormal.
We have attempted to examine this question using an experimental model. Ammonium excretion was measured in dogs with chronic renal disease (i.e., pyelonephritis). Experiments were performed initially when the diseased kidney functioned in concert with a contralateral kidney that was free of disease and hence retained its full complement of nephrons. The control kidney then was removed, and the ammonium excretion rate of the same diseased kidney was measured again. Measurements also were made of the response to the infusion of amino acid precursors of ammonia synthesis before and after removal of the control kidneys. We believe that the data support the view that the average rate of ammonium excretion per nephron increased adaptively to supernormal levels in the residual nephrons of the pyelonephritic kidneys.
Methods
Thirty-seven experiments were performed on ten female mongrel dogs ranging in weight from 10 to 20 kg. In each animal, the urinary bladder was divided into two permanent hemibladders (5) as a preliminary procedure. The terminology used to designate the three successive stages of study has been presented previously (6) ; a summary is included below.
Stage I refers to the initial studies performed in each dog before the induction of renal disease. These experiments were done to establish the patterns of function of the two kidneys before there was any reduction of nephron population.
Stage II refers to the studies performed after chronic pyelonephritis had been induced in the experimental kidney. The mechanism of induction of the lesion and the interval between induction and study have been described in a previous publication (6) . In the stage II studies the diseased and the contralateral control organs were investigated simultaneously.
Stage III refers to the studies performed after the control organ had been removed surgically, when the residual nephrons of the diseased kidney were charged with the entire responsibility for the renal regulation of acid-base balance. Stage III studies were performed from 4 to 27 days after removal of the control organs.
At each stage of study, metabolic acidosis was induced by the exogenous oral administration of ammonium chloride for at least 3 days. In stage I, the dose ranged from 4 to 8 g per day depending upon body weight; in stage II the same or a slightly smaller dose was employed; in stage III the dose of ammonium chloride required to achieve the same degree of metabolic acidosis generally was substantially less. The dose was adjusted to maintain C02 content at about 15 mmoles per L or pH at 7.2 1.0 or both. The animals were fed the same diet throughout the studies.
The dogs were studied in the postabsorptive state without anesthesia. Blood was obtained through an indwelling femoral arterial catheter, and samples were drawn continuously during each urine collection into heparinized tubes containing mineral oil. Urine also was collected anaerobically under oil into sterile tubes.
Glomerular filtration rate was measured by the exogenous creatinine clearance. The creatinine was infused in a 5% mannitol vehicle containing sodium phosphate (30 mmoles per L) buffered to pH 7.4. The rate of infusion was 4.8 ml per minute in stages I and II, but was decreased usually by 50% in stage III (6) . At least three clearance periods of 10 to 20 minutes were obtained before infusion of the amino acid precursor, and an additional three or more periods were obtained to assess the effects of the amino acids. Creatinine was determined according to the method of Bonsnes and Taussky (7) . Ammonia was determined in duplicate or triplicate on all samples by the method either of Nathan and Rodkey (8) or of Conway (9) . Analyses of ammonia were begun immediately after the samples had been collected, and the measurements were made with acid-cleaned glassware in a room containing no stored urine. Titratable acidity also was measured on the urine samples according to the technique previously described (10) using a Radiometer automatic titrator. Arterial pH was determined with an IL meter, model 113, with a 370 C water bath.
In studying ammonium excretion rates by animals with permanent hemibladders, attention must be given to the possibility that ammonia may be added to the urine as it passes through the bladders by virtue of bacterial degradation of urea. To minimize this potential source of contamination, we maintained a program of rigorous bladder care. This involved frequent rinsing of the hemibladders, particularly before each experiment. In stages I and II, the equality of ratios of urinary ammonium and titratable acid excretion to glomerular filtration rate (UNE8V/GFR and UTAV/GFR) between the two kidneys of individual animals made the possibility of random NH8 contamination very unlikely. However, the primary questions asked in these studies made it particularly important to exclude contamination in the stage III experiments. Therefore, an increase in ammonium excretion rate between stages II and III was accepted in any given animal only if the following criteria were met: 1) UNHSV showed no tendency to decrease with consecutive clearance periods; 2) the increase in NH4' excretion in stage III did not occur at the expense of a decrease in UTAV as would occur if NH8 were added distal to the nephron; and 3) the urine pH did not increase by more than 0.8 U between the stage II and III studies. The absolute rate of UNH5V in the control kidneys increased by 36%o between stage I and stage II. This is reflected in Table I by a 22% increase in the ratio UNH8V/GFR despite the 11%o increase in GFR.
In Table II , composite data are shown for the experimental kidneys in each of the three stages of study. This Table includes Table IV . In seven of the eight dogs studied, data were available for the simultaneous response of both diseased and control kidneys in stage II. The mean increment in UNHBV during alanine infusion was 49%o for the diseased kidneys and 48%o for the control organs. The changes in the diseased kidneys between stages II and III are shown for all eight dogs in Table  IV . In stage II the increment averaged 46.1%o. In stage III, the spontaneous excretion rates (i.e., in the presence of acidosis but before amino acid infusion), as already discussed, were greater than they were in the same kidneys in stage II; indeed, in five of the eight animals, the values before alanine administration in stage III exceeded the values during alanine infusion in stage II. The effects of alanine on the adapted kidneys (i.e., in stage III) were as follows: The increments ranged from 0 to 39.9%o in seven animals, and the value was 161%o in the eighth animal (dog 1). The average increase for the total group was 41%o. If the data from dog 1 are excluded, the increment for the group averaged 23.6%o. Despite the decrease in the percentage increment, however, the absolute increments in UNH.V rates after alanine infusion were closely comparable in stages II and III in most of the animals.
In two of the animals in which alanine was infused in stage III, the effects of glutamine were measured in separate experiments. These data are also included in Table IV . In dog 9, the percentage increment was approximately the same with glutamine as with alanine; in dog 8 the response to glutamine was not so marked.
Discussion
The residual nephrons of the diseased kidney of the dog have been found to increase UpH3V adaptively in association with a marked reduction in the available nephron population. Ammonium reduction was measured during sustained metabolic acidosis before (stage II) and after (stage III) the removal of the contralateral control kidney. The rate of Upm18V increased unequivocally in nine of the ten dogs studied, and the increment for the group averaged 90.4%o.
In studies performed before nephrectomy, UNH8V was found to be diminished in the diseased kidneys in relation to the contralateral nondiseased organs; however, the ratios of UNH8V/ GFR in the diseased versus control kidneys were indistinguishable. Thus, in the absence of a marked decrease in total (i.e., bilateral) nephron population, the residual nephrons of the diseased kidney maintain the same level of glomerulotubular balance (with ammonia as the index of -tubular function) as do the nephrons of the contralateral kidney. These observations confirm previous studies in dogs (10) and man (11, 12) with unilateral or predominantly unilateral renal disease.
In further evaluating the significance of the clearance ratios in the stage II studies, consideration must be given to the fact that UNH8V by the control kidneys increased by an average of 36%o between stages I and II. GFR also increased in the control kidneys by 11%. It is of interest, therefore, that the values for UNH8V/GFR in the diseased kidneys in stage II remained equal to those in the control kidneys despite the occurrence not only of an increase in both UNH.V and GFR in the control organ, but an unequal increase in the two functions. Presumably the changes in the control kidneys reflect a limited adaptive increase in both tubular and glomerular function in consequence of the induction of disease (and loss of nephrons) in the experimental organs. The equality of clearance ratios, therefore, could indicate that a similar adaptive increase occurred in the residual urine-forming nephrons of the pyelonephritic organs. In any event, the data would favor the view that whatever factors controlled the relationship between GFR and UNHjV in the control kidney exercised control over these same relationships in the surviving nephrons of the diseased kidney. The response to amino acid infusion in stage II also is of interest in this context. The percentage increase in UNHmV for the diseased kidneys did not differ consistently from that of the control organs, and the mean values for the two groups of kidneys were virtually identical.
It is hard for us to reconcile the foregoing data with randomly distributed structural lesions 'producing a spectrum of defects in ammonia synthetic ability in the involved tubular segments. However, the data do not rule out-the existence of iso-lated defects in a portion of the nephron population. If an appreciable number of nephrons sustained a significant reduction in ammonia synthetic capacity, the equality of clearance ratios would require that GFR be reduced to a proportional degree in these same units (or else in uninvolved nephrons), or that UNH3V be increased in a highly precise manner in the uninvolved segments or units, or both. The response to alanine would require, furthermore, that the noninvolved segments of these nephrons respond in a quantitatively normal fashion to precursor substrate. Finally, these units presumably would contribute to the marked adaptive increase in UNHSV observed between stages II and III.
In addressing himself to the question of UNHBV in renal disease, Relman (3) has pointed out that the equality of UNH3V/GFR ratios between -diseased and contralateral control kidneys does not necessarily exclude specific tubular defects in ammonia synthesis in that blood flow to the tubules might decrease roughly in proportion to GFR; therefore, GFR might be inversely related to the degree of structural damage in functioning nephrons. If future investigations establish the fact that partially damaged nephrons contribute to urine formation in detectable numbers in the usual forms of chronic progressive renal disease, some mechanism, such as the one proposed by Relman, may well subserve the regulation of glomerulotubular balance among the constituent nephrons. However, we believe that a regulatory system, whatever its nature, must be so designed as to maintain a high level of functional organization among the residual nephrons.
One of the intriguing questions raised by these studies relates to the mechanisms of adaptation in ammonium excretion that occurred to a limited degree in the control kidneys between stages I and II and to a more marked degree in the diseased kidneys between stages II and III. (15) have shown that the values for UNH3V tend to decrease in proportion to the decrement in GFR. It is possible, therefore, that with greater chronicity, any adaptive change in UNH8V would parallel the simultaneous adaptation in GFR. It is also possible that the experimental model does not accurately reflect the situation in man, and in this context it must be noted that these animals all had a nonglomerular disease. One conclusion that may be permissible from the variable change in ratios is that it may not be possible to exclude an adaptive increase in UNH,,V on the basis of a normal or even diminished UN~sV/GFR ratio in advanced renal disease in any given patient.
Summary
Maximal rates of ammonium excretion were measured in the chronically diseased kidney of the dog. Studies were performed on both kidneys before disease was induced (stage I). Measurements then were repeated after experimental pyelonephritis had been induced in one kidney, but not in the other (stage II). Finally, the functional patterns were re-evaluated after removal of the control organ under conditions in which the diseased kidney was responsible for the entire contribution to acid-base preservation (stage III). Chronic acidosis of comparable degree and duration was induced at each phase of study by exogenous administration of regulated doses of ammonium chloride. The response to amino acid precursors of ammonia synthesis also was determined before and after the removal of the control organ. In stage I, ammonium excretion values were equal in the two sets of normal kidneys. In stage II, ratios of ammonium excretion to glomerular filtration rate remained equal bilaterally, and the percentage increment after amino acid infusion also was equal bilaterally. In stage III, the spontaneous rate of ammonium excretion increased in the diseased kidneys by an average of 91.6%o.
The response to amino acid infusion persisted in stage III, but was somewhat less than in stage II. The data suggest that in response to a diminution in the total number of functioning nephrons, ammonium excretion per nephron increases adaptively in the residual nephrons.
